David Cragg Cytokinetics Inc (CYTK) insider trading activity

David Cragg is Chief HR & Admin Officer of CYTOKINETICS INC. Currently has a direct ownership of 153,233 shares of CYTK, which is worth approximately $8.51 Million. The most recent transaction as insider was on Mar 07, 2022, when has been sold 5,399 shares (Common Stock) at a price of $36.83 per share, resulting in proceeds of $198,845. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 153K

0% 3M change

0% 12M change

Total Value Held $8.51 Million

David Cragg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2022	SELL Payment of exercise price or tax liability	$198,845 $36.83 p/Share	5,399 Reduced 3.4%	153,233 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$130,125 $37.63 p/Share	3,458 Reduced 2.43%	138,632 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	20,000 Added 11.2%	158,632 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$73,148 $35.32 p/Share	2,071 Reduced 1.44%	142,090 Common Stock
Feb 16 2022	BUY Grant, award, or other acquisition	-	5,008 Added 3.36%	144,161 Common Stock
Nov 09 2021	SELL Open market or private sale	$1,879,200 $41.76 p/Share	45,000 Reduced 24.5%	138,704 Common Stock
Nov 09 2021	BUY Exercise of conversion of derivative security	$434,250 $9.65 p/Share	45,000 Added 22.04%	159,185 Common Stock

Nov 01 2021	SELL Open market or private sale	$872,250 $34.89 p/Share	25,000 Reduced 15.27%	138,704 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$150,000 $6.0 p/Share	25,000 Added 13.73%	157,029 Common Stock
Oct 01 2021	SELL Open market or private sale	$265,975 $35.14 p/Share	7,569 Reduced 5.23%	137,123 Common Stock
Sep 01 2021	SELL Open market or private sale	$257,323 $32.78 p/Share	7,850 Reduced 5.15%	144,692 Common Stock
Aug 02 2021	SELL Open market or private sale	$77,617 $29.67 p/Share	2,616 Reduced 1.69%	152,542 Common Stock
Jul 01 2021	SELL Open market or private sale	$119,478 $19.87 p/Share	6,013 Reduced 3.73%	155,158 Common Stock
Jun 01 2021	SELL Open market or private sale	$324,428 $21.63 p/Share	14,999 Reduced 8.51%	161,171 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$94,494 $6.3 p/Share	14,999 Added 8.12%	169,608 Common Stock
Mar 08 2021	SELL Payment of exercise price or tax liability	$79,639 $19.19 p/Share	4,150 Reduced 2.52%	160,625 Common Stock
Mar 02 2021	BUY Grant, award, or other acquisition	-	25,000 Added 13.17%	164,775 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$40,794 $19.66 p/Share	2,075 Reduced 1.46%	139,775 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$82,019 $18.73 p/Share	4,379 Reduced 2.99%	141,850 Common Stock
Dec 15 2020	SELL Payment of exercise price or tax liability	$223,713 $21.0 p/Share	10,653 Reduced 6.79%	146,229 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$156,994 $9.42 p/Share	16,666 Added 9.87%	152,137 Common Stock

David Cragg

Chief HR & Admin Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Value

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

Operation

Value

Type

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK

Account